Veracyte | VCYT - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Agenus USD 6.21M 4.34M 2026-03
Agilent USD 465M 11M 2026-03
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.63M 4.88M 2026-06
Bruker USD 238.9M 3.2M 2026-06
Heron Therapeutics USD 23.74M 605K 2025-12
Illumina USD 273M 1000K 2026-06
Intrexon USD 10.31M 41K 2024-06
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Laboratory Of America USD 577.2M 26.2M 2026-06
Ligand Pharmaceuticals USD 29.12M 8.29M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 6.37B 908M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Siemens EUR 3.76B 197M 2026-06
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Veracyte USD 55.71M 4.87M 2026-06
Waters USD 405M 11M 2026-06